committee group motion | Q97695005 |
P953 | full work available at URL | http://data.riksdagen.se/dokument/GW02So253 |
http://data.riksdagen.se/dokumentstatus/GW02So253 | ||
P8433 | Swedish Riksdag document ID | GW02So253 |
P1001 | applies to jurisdiction | Sweden | Q34 |
P50 | author | Bodil Valero | Q4942281 |
Gunvor G. Ericson | Q4946932 | ||
Jan Lindholm | Q5956750 | ||
Peter Rådberg | Q6086370 | ||
Thomas Nihlén | Q6156728 | ||
Christopher Ödmann | Q54396872 | ||
P6216 | copyright status | public domain | Q19652 |
P407 | language of work or name | Swedish | Q9027 |
P1031 | legal citation of this text | Mot. 2008/09:So253 | |
P7727 | legislative committee | Committee on Health and Welfare | Q10672943 |
P921 | main subject | medication | Q12140 |
Swedish Medical Products Agency | Q1879124 | ||
P6104 | maintained by WikiProject | Project Riksdagen's documents | Q114364300 |
P179 | part of the series | motions of the 2008-2009 legislative session of the Riksdag | Q97769826 |
P577 | publication date | 2008-09-30 | |
P1476 | title | Anslagsfinansiering av Läkemedelsverket |
Q98410267 | Q98410267 | has immediate cause | P1478 |
Search more.